Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co LtdfiledCriticalGrelan Pharmaceutical Co Ltd
Priority to JP4815676ApriorityCriticalpatent/JPS52130926A/en
Publication of JPS52130926ApublicationCriticalpatent/JPS52130926A/en
Publication of JPS5339490B2publicationCriticalpatent/JPS5339490B2/ja
PURPOSE: Preparations comprising non-narcotic pentazocine (PA) formulated with salicylamide (SAM) which show a high concentration in the blood and analgesic effect with a relatively low dose level of PA and cause little side effects.
COPYRIGHT: (C)1977,JPO&Japio
JP4815676A1976-04-271976-04-27Medicinal composition comprising pentazocine and salicylamide
GrantedJPS52130926A
(en)